Snippet Search

Searching 12,255,145 documents.
Discover how a particular term or phrase is used in scientific literature

Showing 1 to 25 of 323 matching articles

Results per page:

... surface. Most protocols use single agents (  mitomycin 
Combination Intraperitoneal Chemotherapy Is Superior to Mitomycin C or Oxaliplatin for Colorectal Carcinomatosis In Vivo
Combination Intraperitoneal Chemotherapy Is Superior to Mitomycin C or Oxaliplatin for Colorectal Carcinomatosis In Vivo
Cohen, Mark S.; Al-kasspooles, Mazin F.; Williamson, Stephen K.; Henry, David; Broward, Melinda; Roby, Katherine F.
C or oxaliplatin) provided IP. ...
... contrast results using two chemoperfusates:  mitomycin 
Cytoreductive Surgery with Intraperitoneal Hyperthermic Chemotherapy for Malignant Peritoneal Mesothelioma: Mitomycin Versus Cisplatin
Cytoreductive Surgery with Intraperitoneal Hyperthermic Chemotherapy for Malignant Peritoneal Mesothelioma: Mitomycin Versus Cisplatin
Blackham, Aaron U.; Shen, Perry; Stewart, John H.; Russell, Gregory B.; Levine, Edward A.
and cisplatin. ...
... technique, we administered hyperthermic  mitomycin 
Toxicity and Quality of Life after Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy
Toxicity and Quality of Life after Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy
Tuttle, Todd M.; Zhang, Yan; Greeno, Edward; Knutsen, Amy
C into the peritoneal cavity for 90 min. ...
... than expected after CS-HIPEC with  mitomycin 
Antimicrobial Properties of Perfusate Fluid After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CS-HIPEC) with Mitomycin C
Antimicrobial Properties of Perfusate Fluid After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CS-HIPEC) with Mitomycin C
Lange, Krystle N.; McKay, Danielle; Gentry, Brian G.; Franko, Jan
C (MMC), they investigated the ...
... led to the first reports of HIPEC using  mitomycin 
Standard Clinical Protocol for Bidirectional Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Systemic Leucovorin, 5-Fluorouracil, and Heated Intraperitoneal Oxaliplatin in a Chloride-Containing Carrier Solution
Standard Clinical Protocol for Bidirectional Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Systemic Leucovorin, 5-Fluorouracil, and Heated Intraperitoneal Oxaliplatin in a Chloride-Containing Carrier Solution
Mehta, Akash M.; Huitema, Alwin D. R.; Burger, Jacobus W. A.; Brandt-Kerkhof, Alexandra R. M.; Heuvel, Sander F.; Verwaal, Victor J.
C for patients with peritoneal ...
... cisplatin/oxaliplatin 60-130 mg/m2, and  mitomycin 
Isolated Chemotherapeutic Perfusion of Pelvis as Neoadjuvant or Palliative Therapy for Advanced Cancer of the Rectum
Isolated Chemotherapeutic Perfusion of Pelvis as Neoadjuvant or Palliative Therapy for Advanced Cancer of the Rectum
Wanebo, Harold J.; DiSiena, Michael; Begossi, Giovanni; Belliveau, James; Gustafson, Eric
C 10 to 15 mg/m2 (the latter three ...
... patients were treated with intraperitoneal  mitomycin 
Management for Peritoneal Metastasis of Colonic Origin: Role of Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy: A Single Institution’s Experience During Two Decades
Management for Peritoneal Metastasis of Colonic Origin: Role of Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy: A Single Institution’s Experience During Two Decades
Ihemelandu, Chukwuemeka; Sugarbaker, Paul H.
C and 5-FU during the perioperative ...
... Continuous HAI of either 5-fluorouridine or  mitomycin 
Regional chemotherapy for colorectal hepatic metastases: Evidence for improved survival with new drug combinations
Regional chemotherapy for colorectal hepatic metastases: Evidence for improved survival with new drug combinations
Sutanto-Ward, E.; Arisawa, Y.; Tremiterra, S.; Sigurdson, E. R.
C has not previously been reported. ...
... HIPEC using oxaliplatin (200–460 mg/m2) or  mitomycin 
Neoadjuvant Chemotherapy with Bevacizumab May Improve Outcome after Cytoreduction and Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) for Colorectal Carcinomatosis
Neoadjuvant Chemotherapy with Bevacizumab May Improve Outcome after Cytoreduction and Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) for Colorectal Carcinomatosis
Ceelen, Wim; Nieuwenhove, Yves; Putte, Dirk Vande; Pattyn, Piet
C (35 mg/m2). ...
... Tumor cell sensitivity to oxaliplatin, 5FU,  mitomycin 
Drug Sensitivity Testing in Cytoreductive Surgery and Intraperitoneal Chemotherapy of Pseudomyxoma Peritonei
Drug Sensitivity Testing in Cytoreductive Surgery and Intraperitoneal Chemotherapy of Pseudomyxoma Peritonei
Bjersand, Kathrine; Mahteme, Haile; Sundström Poromaa, Inger; Andréasson, Håkan; Graf, Wilhelm; Larsson, Rolf; Nygren, Peter
C, doxorubicin, irinotecan, and cisplatin ...
... for Malignant Peritoneal Mesothelioma:  Mitomycin 
Erratum: Cytoreductive Surgery with Intraperitoneal Hyperthermic Chemotherapy for Malignant Peritoneal Mesothelioma: Mitomycin Versus Cisplatin
Erratum: Cytoreductive Surgery with Intraperitoneal Hyperthermic Chemotherapy for Malignant Peritoneal Mesothelioma: Mitomycin Versus Cisplatin
Blackham, Aaron U.; Shen, Perry; Stewart, John H.; Russell, Gregory B.; Levine, Edward A.
Versus Cisplatin” (DOI ...
... possible, but treated earlier with EPIC (  mitomycin 
Comparison of Two Kinds of Intraperitoneal Chemotherapy Following Complete Cytoreductive Surgery of Colorectal Peritoneal Carcinomatosis
Comparison of Two Kinds of Intraperitoneal Chemotherapy Following Complete Cytoreductive Surgery of Colorectal Peritoneal Carcinomatosis
Elias, Dominique; Benizri, Emmanuel; Pietrantonio, Daniela; Menegon, Paola; Malka, David; Raynard, Bruno
C 10 mg/m² at day 0 and 5-FU 650 mg/m² from ...
... diaphragm was closed prior to HIPEC with  mitomycin 
Intrathoracic Chemoperfusion Decreases Recurrences in Patients with Full-Thickness Diaphragm Involvement with Mucinous Appendiceal Adenocarcinoma
Intrathoracic Chemoperfusion Decreases Recurrences in Patients with Full-Thickness Diaphragm Involvement with Mucinous Appendiceal Adenocarcinoma
Grotz, Travis E.; Mansfield, Paul F.; Royal, Richard E.; Mann, Gary N.; Rafeeq, Safia; Beaty, Karen A.; Overman, Michael J.; Fournier, Keith F.
-C, resulting in little, if any, direct ...
... after HIPC with oxaliplatin (OX) versus  mitomycin 
Severe Electrolyte Disturbances After Hyperthermic Intraperitoneal Chemotherapy: Oxaliplatin Versus Mitomycin C
Severe Electrolyte Disturbances After Hyperthermic Intraperitoneal Chemotherapy: Oxaliplatin Versus Mitomycin C
Rueth, Natasha M.; Murray, Sara E.; Huddleston, Stephen J.; Abbott, Andrea M.; Greeno, Edward W.; Kirstein, Mark N.; Tuttle, Todd M.
C (MMC). ...
... Nakajima et al.24 East Japan RCT Adjuvant 7  Mitomycin 
Long-Term Survival After Gastrectomy for Cancer in Randomized, Controlled Oncological Trials: Comparison between West and East
Long-Term Survival After Gastrectomy for Cancer in Randomized, Controlled Oncological Trials: Comparison between West and East
Markar, Sheraz R.; Karthikesalingam, Alan; Jackson, Daniel; Hanna, George B.
 + fluorouracil following by Oral UFT IV ...
... (n = 34) receiving cisplatin 120 mg and  mitomycin 
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Improves Survival of Patients with Peritoneal Carcinomatosis from Gastric Cancer: Final Results of a Phase III Randomized Clinical Trial
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Improves Survival of Patients with Peritoneal Carcinomatosis from Gastric Cancer: Final Results of a Phase III Randomized Clinical Trial
Yang, Xiao-Jun; Huang, Chao-Qun; Suo, Tao; Mei, Lie-Jun; Yang, Guo-Liang; Cheng, Fu-Lin; Zhou, Yun-Feng; Xiong, Bin; Yonemura, Yutaka; Li, Yan
C 30 mg each in 6000 ml of normal saline at ...
... was 30 mg/m2 doxorubicin, 15 mg/m2  mitomycin 
Complications and Toxicity After Abdominal and Pelvic Hypoxic Stop-Flow Perfusion Chemotherapy: Incidence and Assessment of Risk Factors
Complications and Toxicity After Abdominal and Pelvic Hypoxic Stop-Flow Perfusion Chemotherapy: Incidence and Assessment of Risk Factors
Bree, Eelco; Romanos, John; Tsogkas, John; Askoxylakis, John; Metaxari, Maria; Michalakis, John; Volakakis, Evangelos; Melissas, John; Tsiftsis, Dimitris D.
C and 50 mg/m2 cisplatin. ...
... systemic 5-fluorouracil. The doses of  mitomycin 
Cytoreductive Surgery Combined with Hyperthermic Intraperitoneal Chemotherapy with Oxaliplatin Increases the Risk of Postoperative Hemorrhagic Complications: Analysis of Predictive Factors
Cytoreductive Surgery Combined with Hyperthermic Intraperitoneal Chemotherapy with Oxaliplatin Increases the Risk of Postoperative Hemorrhagic Complications: Analysis of Predictive Factors
Charrier, Thibaut; Passot, Guillaume; Peron, Julien; Maurice, Christelle; Gocevska, Sashka; Quénet, François; Eveno, Clarisse; Pocard, Marc; Goere, Diane; Elias, Dominique; Ortega-Deballon, Pablo; Vaudoyer, Delphine; Cotte, Eddy; Glehen, Olivier
C were 30–50 mg/m2 and doses of cisplatin ...
... (n = 20): CS only, CS followed by HIPEC (  mitomycin 
Intraoperative versus Early Postoperative Intraperitoneal Chemotherapy after Cytoreduction for Colorectal Peritoneal Carcinomatosis: an Experimental Study
Intraoperative versus Early Postoperative Intraperitoneal Chemotherapy after Cytoreduction for Colorectal Peritoneal Carcinomatosis: an Experimental Study
Klaver, Yvonne L. B.; Hendriks, Thijs; Lomme, Roger M. L. M.; Rutten, Harm J. T.; Bleichrodt, Robert P.; Hingh, Ignace H. J. T.
35 mg/m2 at 41.5°C), CS followed by EPIC ...
... effect from the addition of hyperthermia.  Mitomycin 
A Phase I Trial of Oxaliplatin for Intraperitoneal Hyperthermic Chemoperfusion for the Treatment of Peritoneal Surface Dissemination from Colorectal and Appendiceal Cancers
A Phase I Trial of Oxaliplatin for Intraperitoneal Hyperthermic Chemoperfusion for the Treatment of Peritoneal Surface Dissemination from Colorectal and Appendiceal Cancers
Stewart, John H., IV; Shen, Perry; Russell, Greg; Fenstermaker, Joyce; McWilliams, Libby; Coldrun, Faith M.; Levine, Keith E.; Jones, Bradley T.; Levine, Edward A.
C is the most commonly utilized agent for ...
... 1 (3.1) 0 (0.0) NS  Cisplatin/  mitomycin 
Is Fecal Diversion Needed in Pelvic Anastomoses During Hyperthermic Intraperitoneal Chemotherapy (HIPEC)?
Is Fecal Diversion Needed in Pelvic Anastomoses During Hyperthermic Intraperitoneal Chemotherapy (HIPEC)?
Whealon, Matthew D.; Gahagan, John V.; Sujatha-Bhaskar, Sarath; O’Leary, Michael P.; Selleck, Matthew; Dumitra, Sinziana; Lee, Byrne; Senthil, Maheswari; Pigazzi, Alessio
C 0 (0.0) 1 (2.4) NS   ...
... the abdomen was perfused with  mitomycin 
Long-Term Survival of Peritoneal Carcinomatosis of Colorectal Origin
Long-Term Survival of Peritoneal Carcinomatosis of Colorectal Origin
Verwaal, Vic J.; Ruth, Serge; Witkamp, Arjen; Boot, Henk; Slooten, Gooike; Zoetmulder, Frans A. N.
C (35 mg/m2) at 40°C to 41°C for 90 ...
... dose of irinotecan (CPT-11) when used with  mitomycin 
Closed Abdomen Hyperthermic Intraperitoneal Chemotherapy with Irinotecan and Mitomycin C: a Phase I Study
Closed Abdomen Hyperthermic Intraperitoneal Chemotherapy with Irinotecan and Mitomycin C: a Phase I Study
Cotte, Eddy; Passot, Guillaume; Tod, Michel; Bakrin, Naoual; Gilly, François-Noël; Steghens, Aline; Mohamed, Faheez; Glehen, Olivier
C (MMC) for closed abdomen HIPEC. ...
... not been previously investigated. Methods  Mitomycin 
Safety monitoring of the coliseum technique for heated intraoperative intraperitoneal chemotherapy with mitomycin C
Safety monitoring of the coliseum technique for heated intraoperative intraperitoneal chemotherapy with mitomycin C
Stuart, O. Anthony; Stephens, Arvil D.; Welch, Laura; Sugarbaker, Paul H.
C was perfused through the peritoneal ...
... chemotherapy agents included  mitomycin 
Utility of Chemoresponse Assay in Patients Undergoing Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy
Utility of Chemoresponse Assay in Patients Undergoing Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy
Bhagwandin, S.; Naffouje, S.; Salti, G.
C, cisplatin + doxorubicin, or cisplatin ...

Subject


Country

(see all 35)

Publication


Publication Type


Publisher